Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Dulcolax |
| Active Ingredient: | Bisacodyl 5mg |
| Dosage Form: | Enteric coated tablet |
| New Zealand Sponsor: | Sanofi-Aventis New Zealand Limited |
| Manufacturer: | Delpharm Reims SAS, Reims, France |
| Product: | Dulcolax |
| Active Ingredient: | Bisacodyl 10mg |
| Dosage Form: | Suppository |
| New Zealand Sponsor: | Sanofi-Aventis New Zealand Limited |
| Manufacturers: | Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany Istituto de Angeli SrL, Florence, Italy |
| Product: | Fucidin |
| Active Ingredient: | Sodium fusidate 250mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | LEO Pharma Limited |
| Manufacturer: | Laboratoires Leo SA, Vernouillet, France |
| Product: | Ondansetron ODT-DRLA |
| Active Ingredient: | Ondansetron 4mg |
| Dosage Form: | Orodispersible tablet |
| New Zealand Sponsor: | Dr Reddy’s New Zealand Limited |
| Manufacturer: | Dr Reddy’s Laboratories Limited, Bachupally, India |
| Product: | Ondansetron ODT-DRLA |
| Active Ingredient: | Ondansetron 8mg |
| Dosage Form: | Orodispersible tablet |
| New Zealand Sponsor: | Dr Reddy’s New Zealand Limited |
| Manufacturer: | Dr Reddy’s Laboratories Limited, Bachupally, India |
Dated this 3rd day of May 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).